Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Jozsef Lovey"'
Autor:
Wafaa Ayesh, Azza Adel Ibrahim Hassan, Hassan Jaafar, Ola Khorshid, Alessandro Laviano, Jozsef Lovey, Mervat Mahrous, Enas Mogawer, Haneen Molla, Ahmed Morsy, Krystel Ouaijan
Publikováno v:
Clinical Nutrition ESPEN. 55:267-276
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8f120301f4c462816f03c170e5f682f2
https://doi.org/10.1016/j.clnesp.2023.03.009
https://doi.org/10.1016/j.clnesp.2023.03.009
Publikováno v:
European Journal of Surgical Oncology.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8ba91794abe00ab25ad4da9c8a0eb04e
https://doi.org/10.1016/j.ejso.2023.02.007
https://doi.org/10.1016/j.ejso.2023.02.007
Autor:
Erika Tóth, Zsófia Kürönya, Edina Soós, Tamás Pintér, Henriett Butz, Zsolt Horváth, Erzsébet Csernák, Vince Kornél Grolmusz, Judit Székely, Tamás Straussz, József Lövey, Levenete Jánvári, László Báthory-Fülöp, Péter Nagy, Csaba Polgár, Attila Patócs
Publikováno v:
Acta Oncologica, Vol 63, Iss 1 (2024)
Recent developments in molecular genetic testing methods (e.g. next-generation sequencing [NGS]-panels) largely accelerated the process of finding the most appropriate targeted therapeutic intervention for cancer patients based on molecularly targeta
Externí odkaz:
https://doaj.org/article/2378294547c842d0a17ba88dade9265b
Publikováno v:
Pathology and Oncology Research, Vol 30 (2024)
Background: Several factors can affect overall survival of head and neck cancer (HNC) patients, including characteristics of the cancer disease and response to treatments. However, patients’ nutritional status and the effectiveness of medical nutri
Externí odkaz:
https://doaj.org/article/518eb9d7786e45b7ac8632529dd26ab7
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Sebastian Kehrloesser, Simon Oberst, Willien Westerhuis, Astrid Wendler, Anke Wind, Harriët Blaauwgeers, Jean‐Benoit Burrion, Péter Nagy, Gunnar Saeter, Eva Gustafsson, Paolo De Paoli, József Lovey, Claudio Lombardo, Thierry Philip, Dominique deValeriola, Marjet Docter, Femke Boomsma, Mahasti Saghatchian, Marek Svoboda, Irene Philip, Francesco Monetti, Henk Hummel, Gordon McVie, Renée Otter, Wim vanHarten
Publikováno v:
Molecular Oncology, Vol 15, Iss 5, Pp 1277-1288 (2021)
There is a persistent variation in cancer outcomes among and within European countries suggesting (among other causes) inequalities in access to or delivery of high‐quality cancer care. European policy (EU Cancer Mission and Europe’s Beating Canc
Externí odkaz:
https://doaj.org/article/0fc51c13718f4072a9e9cca58fac428f
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
Since the introduction of next-generation sequencing, the frequency of germline pathogenic TP53 variants and the number of cases with unusual clinical presentations have been increasing. This has led to the expansion of the classical Li–Fraumeni sy
Externí odkaz:
https://doaj.org/article/5f4d91947b754b4c97dac51232637781
Autor:
Zsuzsa S. Kocsis, Gyöngyi Farkas, András Bajcsay, Márta Kun-Gazda, József Lövey, Gyula Ostoros, Tamás Pócza, András Herein, Katalin Ladányi, Gábor Székely, Zsolt Markóczy, Zoltán Takácsi-Nagy, Csaba Polgár, Zsolt Juranyi
Publikováno v:
Frontiers in Oncology, Vol 11 (2022)
Due to the profound difference in radiosensitivity of patients and various side effects caused by this phenomenon, a radiosensitivity marker is needed. Prediction by a marker may help personalise the treatment. In this study, we tested chromosomal ab
Externí odkaz:
https://doaj.org/article/e3c230458481433faae4e161f5e78458